Compass Therapeutics (CMPX) Change in Acquisitions & Divestments (2023 - 2026)
Compass Therapeutics' Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $83.3 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 128.68% to $83.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $148.2 million, a 10.87% increase, with the full-year FY2025 number at $101.3 million, down 24.97% from a year prior.
- Change in Acquisitions & Divestments hit $83.3 million in Q1 2026 for Compass Therapeutics, up from $24.1 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for CMPX hit a ceiling of $83.3 million in Q1 2026 and a floor of $13.9 million in Q3 2025.
- Historically, Change in Acquisitions & Divestments has averaged $38.6 million across 4 years, with a median of $36.4 million in 2025.
- Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 59.52% in 2025 and later skyrocketed 128.68% in 2026.
- Tracing CMPX's Change in Acquisitions & Divestments over 4 years: stood at $51.4 million in 2023, then plummeted by 50.91% to $25.2 million in 2024, then fell by 4.49% to $24.1 million in 2025, then soared by 245.79% to $83.3 million in 2026.
- Business Quant data shows Change in Acquisitions & Divestments for CMPX at $83.3 million in Q1 2026, $24.1 million in Q4 2025, and $13.9 million in Q3 2025.